Carbonic anhydrase inhibitors. Part 54 - Metal complexes of heterocyclic sulfonamides: A new class of antiglaucoma agents

9Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Metal complexes of heterocyclic sulfonamides possessing carbonic anhydrase (CA) inhibitory properties were recently shown to be useful as intraocular pressure (IOP) lowering agents in experimental animals, and might be developed as a novel class of antiglaucoma drugs. Here we report the synthesis of a heterocyclic sulfonamide CA inhibitor and of the metal complexes containing main group metal ions, such as Be(II), Mg(II), Al(III), Zn(II), Cd(II) and Hg(II) and the new sulfonamide as well as 5-amino-1,3,4-thiadiazole-2-sulfonamide as ligands. The new complexes were characterized by standard physico-chemical procedures, and assayed as inhibitors of three CA isozymes, CA I, II and IV. Some of them (but not the parent sulfonamides) strongly lowered IOP in rabbits when administered as a 2% solution into the eye.

Cite

CITATION STYLE

APA

Supuran, C. T., Scozzafava, A., & Jitianu, A. (1997). Carbonic anhydrase inhibitors. Part 54 - Metal complexes of heterocyclic sulfonamides: A new class of antiglaucoma agents. Metal-Based Drugs, 4(6), 307–315. https://doi.org/10.1155/MBD.1997.307

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free